Skip to main content
APEI logo

APEI · American Public Education Inc

Track APEI — free
$42.18 +1.09 (+2.65%) At close · Sep 30
Market Cap
$756.59M
Shares
18.30M
Volume · Sep 30 339.41K Avg daily vol (3M) 303.32K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$42.18 Open$41.26 Day$40.88–42.61 52W close$30.67–60.86 Avg vol 30d260K Short int2.0M · 10.9% float · 9.8d Short vol26% Last earningsAug 10, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 12, 2026 Est · unconfirmed · in 6 wks
filed Aug 10, 2026
call held Aug 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$668.01M
Trailing 12 months
Net income (TTM)
$45.67M
Trailing 12 months
Revenue growth YoY
+5.5%
Year over year
Operating margin
9.6%
Trailing 12 months
P / E (TTM)
16.9
Trailing earnings · reciprocal yield 5.9%
FCF yield
9.3%
TTM · current market cap
Return on invested capital
27.3%
Trailing 12 months
Net cash
$135.54M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.1%
Year over year · more shares
Price change (1Y)
+5.0%
Trailing year
Short interest
10.9%
Latest settlement · 9.8 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 10, 2026
Q2 FY26

TL;DR. APEI raised full-year 2026 guidance on revenue, net income, adjusted EBITDA, and diluted EPS after Q2 results showed adjusted EBITDA up 36.8% with 275 bps of margin expansion, completed the institutional combination creating one HLC-accredited institution, and reported Health+ revenue growth of 11% on enrollment gains.

Bullish
  • + Raised full-year 2026 guidance on revenue, net income, adjusted EBITDA, and diluted EPS.
  • + Q2 adjusted EBITDA grew 36.8% with 275 bps of margin expansion year over year.
  • + Health+ revenue grew 11% to $86.2 million and segment swung to operating income from a prior-year loss.
  • + Military+ segment adjusted EBITDA margin expanded 150 bps to 29.4% with operating income up 10.6%.
Bearish
  • − Active duty channel headwinds from Middle East deployments continue to pressure Navy, Air Force, and Marine enrollments.
  • − President of Health+ Division Mark Arnold is leaving the company.
  • − Non-core student segments have experienced increased cost per lead and lower enrollments, with Q3 Health+ enrollment growth decelerating to approximately 2.5%.
  • − Q3 2026 guidance includes a revenue timing shift moving approximately $6 million of revenue and $4 million of adjusted EBITDA from Q3 into Q4.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol High
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −14%
below
Price vs 50-day avg −8%
below
RSI (14) 41
neutral
MACD trend Negative
52-week position 38%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −8%
trailing
6-month return −27%
trailing
YTD return +12%
this year
Relative strength −40%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $46 › 200d $49 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +36 funds added
Insider flow Distributing
Net -$397.1K over 90 days · 100% sells
Short interest Rising
10.94% of float · ▲ +6.6% MoM · 9.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
209 holders — near 3-yr high, broad support
Squeeze score 75
high risk · 0–100
Fundamentals
Excellent
Revenue growth +33%
Y/Y
EPS growth +147%
Y/Y
Free cash flow $46.1M
Valuation P/E 17
below peers
Balance sheet $79.4M
net cash
Quant / Vol
risk profile
High
Volatility 44%
annualized · 1-yr
Max drawdown −33%
past year
ATR 4.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 5
Latest guidance · from the 8-K filed Aug 10, 2026
Third Quarter 2026
Diluted Earnings per Share GAAP Initiated $0.18 – $0.29
prior qtr $0.52 midpoint −54.8% QoQ
Full Year 2026
Capital Expenditures Initiated $25M – $28M
Guided vs delivered · last 5 settled
Earnings per diluted share fourth quarter of 2021
guided $0.31 – $0.38
$0.50 Beat +44.9%
Earnings per diluted share third quarter of 2021
guided $0.00 – $0.05
$-0.01 Miss −140.0%
Net income per diluted share first quarter of 2021
guided $0.39 – $0.44
$0.49 Beat +18.1%
Diluted earnings per share fourth quarter of 2020
guided $0.41 – $0.46
$0.47 Beat +8.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−14% Bearish
Price vs 50-day avg
−8% Bearish
RSI (14)
41 Neutral
MACD trend
Negative Bearish
52-week position
38% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $46 › 200d $49 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +36 funds added
Insider flow Distributing
Net -$397.1K over 90 days · 100% sells
Short interest Rising
10.94% of float · ▲ +6.6% MoM · 9.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
209 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $31 Now $42 · 38% Range high $61
vs 200-day avg -14% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $49.88M Six Months Ended June 30, 2026 —
Adjusted EBITDA Margin non-GAAP 12% 2Q26 —
EBITDA $43.28M Six Months Ended June 30, 2026 —
Health+ Total Student Enrollment 19,600 Q2 2026 —
Military+ Net Course Registrations 98,300 Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Education & Training Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
APEI
American Public Education Inc
this stock
$756.59M +11.6% +33.0% 17.0 10.9%
EDU
New Oriental Education & Technology Group Inc.
$8.75B +0.8% +15.5% — 2.0%
TAL
TAL Education Group
$6.66B +10.6% +33.7% — 3.7%
LAUR
Laureate Education, Inc.
$5.15B +13.3% +19.5% 17.0 3.1%
CVSA
Covista Inc.
$4.18B +18.1% +9.3% 17.4 5.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
209
% held
107.3%
Net QoQ
-273.9K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
228
View
Short & Settlement
Short Interest Rising
Shares short
2.0M
Days to cover
9.8d
Change
+124.3K sh
View
Short Volume
Short vol %
26%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
477
Value
$21.4K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
40.6%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$397.1K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$648.9M
Net income (FY)
$31.6M
EPS diluted
$1.36
View
Buybacks
Authorized
shares 181.4K
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 10, 2026
This year
10
View
Proposed Sales
Value
$405.3K
Shares
8.8K
Filed
Aug 12, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 10, 2026
View
Investor Relations
Latest news
American Public Education, Inc. U…
Published
Aug 11, 2026
View

Performance

5D 20D 120D MTD YTD
APEI +1.9% -8.0% -27.4% -7.6% +11.6%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY +2.6% -8.1% -39.6% -7.0% -0.3%

Capital returns

Buyback program · as of Dec 31, 2025
Authorized
shares 181,387
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1201792 CUSIP 02913V103 13F (30d) 7 filings 4 filers Visit website Investor relations